Project Grant HT94252310213
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
Trustees of Indiana University was awarded a $7.8 million project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop pharmacotherapies for the treatment of hydrocephalus and associated conditions from September 1, 2023 through August 31, 2027. Under this award, Indiana University will leverage its expertise in biomedical research to investigate medical solutions targeted toward the military health system....
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
Trustees of Indiana University was awarded a $3,953,620 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2023. The grant will fund preclinical testing of a TRPV4 antagonist for the treatment of hydrocephalus in a porcine model through April 30, 2027. Purdue University was issued a subaward as part of the project to use a recently characterized porcine model of post-hemorrhagic hydrocephalus to study hydrocephalic...
The Trustees of Indiana University received a $950,999 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through May 2025 to target EZH2-HOTAIR in order to block platinum-induced ovarian cancer stem cell enrichment and reduce recurrence. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
The Trustees of Indiana University were awarded a $1,562,299 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2022 to July 2025 to investigate the genomic determinants of PIK3CA mutation-driven breast cancer initiation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The Defense Health Agency awarded a $622,008 project grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on November 1, 2024, with a completion date of October 31, 2026, supports research on "The SAGA Complex as an Essential Regulator of Abnormal Transcription Through De Novo DNA Topology Interactions in Multiple Myeloma." This project grant aims to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
The Trustees of Indiana University were awarded a $956,104 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 2022 to May 2026 to decipher the role of progesterone in ovarian cancer risk for BRCA mutation carriers. Through this award, Indiana University researchers will investigate medical solutions for the battlefield and transform health care for service members and the...